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Wednesday, February 24, 2010 719ashowed no structural defects compared to control littermates. Additionally, ex-
amination of these hearts by immunofluorescence microscopy revealed normal
myofibrillar structure and localization of the transgenic protein to intercalated
disks, as normally seen with the endogenous protein. Protein markers for car-
diomyopathy were examined by qPCR and revealed no difference between
non-transgenic and transgenic animals. Echocardiography and magnetic reso-
nance imaging of the N-RAP transgenic animals revealed no significant struc-
tural or functional differences when compared to control littermates at 12
weeks of age. Based on these data, it does not appear that overexpression of
N-RAP directly leads to an observable cardiac phenotype. The alternative hy-
pothesis that upregulation of N-RAP in dilated cardiomyopathy is compensa-
tory remains to explored.
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Extracellular Matrix Remodelling in an Ovine Model of Ageing and Heart
Failure
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We sought to establish a model of heart failure (HF) encompassing young and
aged animals to determine if alterations in the amount of cardiac extracellular
matrix (ECM) occur in ageing and whether these changes are similar to those in
HF.
HF was induced in sheep aged 18 months (young) and those over 8 years (old)
by 4 weeks rapid right ventricular pacing (3.5Hz). Paraffin-embedded left ven-
tricular (LV) samples were stained with picro-sirius red. Interstitial collagen
was visualised by polarised light microscopy. LV protein extracts were as-
sessed for MMP activity using gelatin zymography. Statistical significance
was calculated using the mean 5 SEM and a t-test or by 2-way ANOVA.
LV diameter increased with age (OC) compared to young controls (YC)
(3.0450.2cm vs.2.4450.14cm, n=4-13, P<0.05), in young heart failure
(YF) compared pre-pacing (3.8250.1cm vs. 2.4450.1cm, n=13, P<0.001)
and in old heart failure (OF) compared to pre-pacing (3.8750.1cm vs.
3.0450.2cm, n=4, P<0.05). Collagen content increased in OC compared to
YC (2.2750.4% vs. 0.9650.1%, n=5, P<0.05) and in YF compared to YC
(2.6250.3% vs. 0.9650.1%, n=5-8, P<0.001), and decreased in OF compared
to YF (1.2650.4% vs. 2.6250.3%, n=4-8, P<0.01). Normalised MMP-2 ac-
tivity increased in OC (1.5250.08), YF (1.6650.14) and OF (1.7450.17)
compared to YC (0.9850.22, P<0.05, n=6-8).
The commonality of these changes seen in ageing and HFmay indicate that car-
diac ECM remodelling is important in the predisposition of ageing to the devel-
opment of HF.
All procedures accord to The UK Animals (Scientific Procedures) Act, 1986.
This work was supported by the British Heart Foundation and EU
‘‘Normacor’’.
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Previously we have characterized the physiological heart hypertrophy which
occurs during pregnancy. However, the underlying molecular mechanisms of
pregnancy-induced hypertrophy are still not elucidated. Here we performed
Western Blot analysis together with high resolution confocal microscopy to
identify the key signaling molecules involved in the pregnancy-induced heart
hypertrophy in non-pregnant in diestrus stage (NP), late pregnant (LP), 24
hours post partum (PP1) and 7 days post partum (PP7) mice. Western Blot anal-
ysis of heart lysates showed that phospho-AKT protein levels were decreased
~ 7 fold at the end of pregnancy (N=4NP and N=4 LPmice). Interestingly, AKT
activity was restored one day post-partum to levels comparable to NP. There
were no significant changes in total or phosphorylated levels of ERK1/2 with
pregnancy. The calcium/calmodulin-dependent serine-threonine phosphatase
Calcineurin, which has been shown to be upregulated in pathological cardiac
hypertrophy, was significantly downregulated at the end of pregnancy, and
this downregulation was reversed 1 day after partum. The phosphorylation of
the signal transducer and activator of transcription 3 (STAT3), but not its total
protein levels, was also significantly lower at the end of pregnancy and was re-
stored completely one day post-partum.Although therewas a tendency in reduc-
tion of phospho-GSK protein levels in the LP group, this reduction was not
statistically significant. High resolution confocal microscopy demonstrated
that pregnancy is associated with relocalization of AKT and pAKT to the nu-
cleus, which is partially reversed 24 hours post-partum. While the subcellulardistribution of ERK1 and pERK was not regulated by pregnancy, the nuclear
labeling of P38, JNK1and pJNKwas significantly upregulated at the end of preg-
nancy. Although pJNK localization disappeared completely from the nucleus in
the PP1 group, P38 and JNK1 nuclear labeling remained high 24 hours PP.
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Gper Activation Inhibits Mitochondria Permeability Transition Pore
Opening Via Erk Phosphorylation and Provides Cardioprotection after
Ischemia-Reperfusion
Jean Chrisostome Bopassa, Ligia Toro, Enrico Stefani.
UCLA School of Medicine, Los Angeles, CA, USA.
Recently, several studies have demonstrated G protein coupled receptor 30
(GPER) can directly bind to estrogen and mediate its action. We investigated
the role and the mechanism of estrogen-induced cardioprotection after ische-
mia-reperfusion using a specific GPER agonist G1. Isolated hearts from male
mice were perfused using Langendorff technique with oxygenated (95% O2
and 5% CO2) Krebs Henseleit buffer (control), with addition of G1 (1mM),
and G1 (1mM)þPD98059 (10mM) to investigate the involvement of Erk path-
way. After 20 min of perfusion, hearts were subjected to 20 min global normo-
thermic (37C) ischemia followed by 40min reperfusion. During the course of
experiment cardiac function was measured and myocardial necrosis was eval-
uated by triphenyltetrazolium chloride (TTC) staining at the end of the reper-
fusion. Mitochondria were isolated after 10 minutes of reperfusion to assess the
calcium load required to induce mPTP opening. G1 treated hearts developed
better functional recovery with higher rate pressure product (RPP,
61405264 vs. 26405334 mmHgxbeats/min, p<0.05). The infarct size de-
creased significantly in G1 treated hearts (2152% vs. 4653% p<0.001) and
the Ca2þ load required to induce mPTP opening increased (2.450.06 vs.
1.650.11 mM/mg mitochondrial protein, p<0.05) as compared to the controls.
The addition of PD 98059 significantly prevents G1 effect on heart function
RPP (4120546 mmHgxbeats/min, p<0.05), infarct size (5352%) and calcium
retention capacity (1.450.11mM/mg mitochondrial protein p<0.05) These
results suggest that GPER activation inhibits the mPTP opening and provide
a cardioprotective effect after ischemia-reperfusion and this effect is mediated
by Erk pathway. Supported by NIH and AHA.
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Opposite Production of Reactive Oxygen Species by Complexes I and III
during Heart Ischemia/Reperfusion
Jean Chrisostome Bopaassa, Netanel Feivel Zilberstein, Ligia Toro,
Enrico Stefani.
UCLA School of Medicine, Los Angeles, CA, USA.
In mitochondria, the main reactive oxygen species (ROS) generators are com-
plexes I and III. Mitochondrial ROS generation has been implicated in cellular
damage occurring in a variety of pathologies including ischemia/reperfusion
(I/R). Most of the studies have observed an increase of ROS production after
I/R. However, there is evidence of an increase of ROS production after cardi-
oprotection by preconditioning interventions.
We investigated the differential production of ROS by complex I and III in I/R
and sham isolated mitochondria heart mice, and the action of pro-apoptotic
drugs (rotenone and antimycin A) on ROS production by these complexes in
sham animals.
Mitochondrial ROS generation by both complexes was measured using amplex
red in the presence of horseradish-peroxidase. Specific substrates for complex I
(glutmate/malate) and complex II (succinate), and the inhibitors (rotenone and
antimycin-A) were used. Mitochondria from I/R mice produced more ROS
thanmitochondria from shamwhen the substrate for complex I was used. In con-
trast, with the substrate of complex II, mitochondria from I/Rmice produced less
ROS than sham. Application of rotenone and antimycin-A in mitochondria from
sham heart significantly increased ROS production when the substrate for the
complex Iwas used. Surprisingly, these inhibitors decreased theROSproduction
when the substrate for the complex II was used. This data indicate the ambivalent
production of ROS by the respiratory chain complexes I and III, and suggest op-
posite role of ROS depending on the complex being cardio-deleterious for com-
plex I and cardio-protective for complex III. Supported by NIH and AHA.
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720a Wednesday, February 24, 2010Subcellular fractionation of a complex proteome (cardiac tissue) allows for en-
richment of a subset of low abundant proteins. This permits more in depth anal-
ysis of the proteome by reducing the complexity. Adult rat cardiac tissue was
made ischemic by ligating the left anterior descending coronary artery in vivo
for 1 hour with no reperfusion, and the healthy remote area was differentiated
from the ischemic tissue by staining with Evans Blue dye after harvesting the
heart. A series of differential centrifugation steps produced nuclear, mitochon-
drial, cytoplasmic, microsomal, and sarcomeric fractions of rat ischemic and
remote healthy tissue. The sarcomeric fractions of the remote vs ischemic
cardiac tissue were digested with trypsin, and the peptides were labeled with
isobaric tags for relative quantitation (iTRAQ). The labeled peptides were
then fractionated with an Agilent 3100 OFFGEL fractionator, which separated
the peptides in 12 fractions based on their isoelectric point from pH 3-10. The
12 fractions from the OFFGEL were run on a Dionex U-3000 nano LC coupled
to a ThermoFinnigan LTQ running in PQD (pulsed Q dissociation) mode to de-
tect the low mass reporter ions of the isobaric tags on the peptides. The peptides
were analyzed with MASCOT (MatrixScience), and Scaffold v2.5.2 Qþ with
a minimum of two unique peptides and a level of confidence set at 95%.
Five-fold more proteins were identified when the labeled digests were fraction-
ated with OFFGEL compared to no fractionation prior to LC-MS/MS. With
a one hour ischemic event, we found approximately 11% of the detected pro-
teins in the sarcomeric fraction had changed at least 1.5 fold. Therefore, this
in-solution method incorporating sub-proteomic fractionation in conjunction
with OFFGEL separation may be an approach for discovery of relative protein
changes in cardiac tissue.
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Contractile Function is Altered by Regulation of HO-1 Activity in Single
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Heme oxygenase-1 (HO-1) is a membrane protein upregulated in response to
oxidative stress that confers cardioprotection. The therapeutic potential of
HO-1 can be assessed by examining cardiomyocytes survival and function us-
ing cobalt protoporphyrin (CoPP) or tin protoporphyrin (SnPP) to increase or
inhibit HO-1 activity, respectively. Whether altered HO-1 function affects
cardiomyocyte contractility, however, is unknown. Thus, we determined the
effects of CoPP (n=11), SnPP (n=15), or PBS (control, n=15) on in vitro single
intact adult cardiomyocyte contraction and relaxation using video microscopy
and calcium imaging (IonOptix) at 0.5, 1 and 2Hz. At 0.5Hz there was no dif-
ference in the rate or magnitude of shortening between groups, and all cells had
similar fractional shortening (FS) normalized to peak calcium (FS/Ca2þ). FS/
Ca2þ was, however, greater at 1Hz and 2Hz in SnPP-treated cells, while
CoPP- and PBS-treated cells maintained similar FS/Ca2þ relationships across
frequencies (p<0.05). Intriguingly, while SnPP-treated cells increased
contraction at faster pacing, only 53%of those cells contractingat 0.5Hzbeat syn-
chronously at 1Hz, compared to 100% of CoPP-treated cells and 80% of PBS-
treated cells. This difference became more pronounced at 2Hz, as only 26% of
SnPP-treated cells and 60%of PBS treated cells able to follow stimulation, while
100%ofCoPP-treated cells continued to beat synchronously. Similarly, although
time to 90% relaxation was not different between groups at 0.5Hz, it was signif-
icantly faster in CoPP- vs. SnPP-treated cells at 2Hz (p<0.05). These results sug-
gest that increasingHO-1 activity via CoPP treatmentmaintains cell viability un-
der stress, while SnPP- induced HO-1 inhibition reduces survivability at higher
pacing frequencies. The mechanisms behind this action are unknown, but may
be partially due to HO-1-induced calcium desensitization of the myofilament.
Supported by NSF GRFP (SGN) and NIH HL086709 (MA, MR).
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Imperial College London, London, United Kingdom.
Phosphorylation occurs on serine and threonine residues and plays important
roles in the regulation of contractile proteins. In heart failure changes in levels
of phosphorylation are reported in a number of cardiac sarcomeric proteins. O-
linked-N-acetylglucosamine (O-GlcNAc) modification is another possible
posttranslational modification on serine and threonine residues and recent pub-
lications reported mapping ofO-GlcNAcmodification sites in some rat contrac-
tile proteins, including myosin heavy chain (MHC), actin, cardiac troponin I
and myosin light chains (MLC1 and MLC2). O-GlcNAc modification on nor-
mal donor hearts (49yr F and unknown) and hypertrophic obstructive cardio-myopathy myectomy samples (33yr M and 42yr M) were studied. Cardiac myo-
fibrils were isolated and the O-GlcNAc groups labelled using an enzymatic
labelling system in the presence of PUGNAc (inhibits O-GlcNAc removal en-
zyme O-GlcNAcase) and protease inhibitors. This method allows coupling of
an azido modified N-acetylgalactosamine (UDP-GalNAz) to O-GlcNAc using
the mutant enzyme Y289L b1,4-galactosyltransferase (Y289L GalT). The la-
belled groups were detected by reacting the azide group with an alkyne bearing
the tetramethylrhodamine (TAMRA) fluorescent tag for direct imaging follow-
ing SDS-PAGE. The gel was post-stained with a total protein stain for analysis
with densitometry. The labelling process showed no impact on myofibril pro-
tein profiles when native and labelled myofibrils were compared. Preliminary
results showed thatO-GlcNAcylation profiles vary between samples with a total
of 7 proteins identified. Strong TAMRA signals from a-actinin andMLC1were
observed in all the four myofibrils samples. In three of the samples the proteins
actin, tropomyosin (Tm) and myosin binding protein-C (MyBP-C) were posi-
tively labelled. MHC and desmin O-GlcNAcylation were observed in one of
the four subjects. This enzymatic labelling method will be investigated further
for possibility of quantification and methods for mapping sites of these modi-
fications with mass spectrometry will be explored.
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Cannabinoid (CB) Receptors are not Involved in A-955840 Induced
Negative Inotropic Effects in Isolated Cardiac Myocytes
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Michael Meyer, James Limberis, Jonathon Green, James Polakowski,
Ruth L. Martin, Bryan F. Cox, Gary A. Gintant.
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A-955840, a selective CB2 agonist, has been shown to elicit concentration-de-
pendent decreases in cardiac contractility in the anesthetized dog (decreased
maximal velocity of left ventricular pressure development [LV dP/dt max]).
However, it is unknown whether this represents a direct effect or a response de-
pendent on other factors (such as autonomic tone and neurohumoral factors)
present in vivo. This study examined if A-955840 had a direct effect on con-
tractility of isolated cardiac myocytes, and if so to determine the potential in-
volvement of CB1 and CB2 receptors. Contractility was assessed in vitro using
percent changes in maximal shortening velocity of sarcomeres (dL/dt max) and
fractional shortening of sarcomere length (FS) in rabbit left ventricular myo-
cytes. A-955840 reduced dL/dt max and FS in a reversible and concentra-
tion-dependent manner with an IC50 of 11.4 mg/mL (based on dL/dt max) which
is similar to the IC50 value of 5.5 mg/mL based on the effects of A-955840 on
LV dP/dt max in anesthetized dogs. A-955840 (4.0 mg/mL) reduced myocyte
contractility (%FS) to a similar extent in the absence and presence of a CB2
antagonist, SR-2 (24.0 5 3.4 vs. 23.1 5 3.0 %, n=5) or a CB1 antagonist,
rimonabant (18.85 2.3 vs. 19.85 2.7 %, n=5). A-955840 (4.0 mg/mL) also
reduced L-type calcium current of rabbit ventricular myocytes (1.05 5 0.11
vs. 0.705 0.12 nA, n=5, P<0.01). These results suggest that A-955840 exerts
direct negative inotropic effects on isolated rabbit ventricular myocytes, which
is mediated by neither CB1 nor CB2 receptors, and consistent with off-target
negative inotropy mediated by inhibition of the cardiac L-type calcium current.
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Effects of Development of Compensatory Hypertrophy on Force
Frequency and Beta-Adrenergic Responses
Kaylan M. Haizlip, Paul M. L. Janssen.
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Background: The progression to heart failure involves two steps: compensatory
hypertrophy, a process where contractile function is enhanced and myocyte size
is enlarged, is followed by decompensatory hypertrophy and myocardial weak-
ening. In our current study we aim to understand the temporal resolution of the
development of compensatory hypertrophy through the analysis of functional
and molecular changes. At present, we are assessing the impact of these
changes on contractile modulators through analysis of effects on frequency
and beta-adrenergic regulation.
Methods: Trabeculae are excised from the right ventricular free wall of New
Zealand White rabbits. Thin linear muscle preparations are then suspended in
culture media at high preload and stimulated to contract for up to 24 hours at
1 Hz. At 0-2, 6-8, 12, 18, or 24 hours the effects on either frequency-dependent
or beta-adrenergic regulation are measured. Data is analyzed in real-time
through customized Labview software.
Results: We have shown that during the progression of compensatory hypertro-
phy the beta-adrenergic response shifts to the left indicating a higher sensitivity
with increasing culture time. Changes in frequency from 1 to 4 Hz of trabeculae
cultured from 0-24 hours lead to an increase in developed force of 37% at 0-2
hours (n=5), 53% at 6-8 hours (n=7), 20% at 12 hours (n=6), 30% at 18 hours
(n=6) and a decrease of 69% at 24 hours (n=4). This suggests that the
